We investigated right ventricular function after infusion of unwashed shed blood collected from mediastinal and chest tube drainage. Changes in thromboxane B 2 (TXB 2 ) and 6-keto-PGF 1α , which are stable metabolites of thromboxane A 2 (TXA 2 ) and prostacyclin respectively, were also investigated. The amount of infused shed blood was 484±76 ml (mean±SD). Right ventricular ejection fraction decreased rapidly after the infusion and did not return to its original level until 120 minutes later (P<0.05). Mean pulmonary artery pressure rose after infusion of the shed blood (P<0.05). The TXB 2 level in the unwashed shed blood was about 20,000 times higher than the preoperative plasma level. The plasma TXB 2 level at 30 minutes after the infusion was significantly elevated (P<0.05), and at 120 minutes it had returned to the original level. Unwashed shed blood may contain vasoactive substances that induce the release of TXA 2 and increase right ventricular afterload.
Many techniques which might reduce the need for homologous blood transfusion have been investigated in order to reduce the risk of adverse immunologic reactions and the transmission of life-threatening infectious diseases such as the HIV or hepatitis viruses. Infusion of unwashed shed blood from noncontaminated drainage is one technique that has been used during cardiac surgery 1, 2 .
Unwashed shed blood autotransfusion may be associated with activation of haemostatic and fibrinolytic systems 1, 3 , impaired platelet function 4 and release of vasoactive or immunoactive substances such as cytokines 5 , complement 6 and phospholipase A 2 7 . Unwashed shed blood infusion has been shown to induce pulmonary insufficiency 8, 9 , possibly caused by pulmonary embolism of microaggregates and vasoactive substances. Activated platelets release thromboxane A 2 (TXA 2 ) which induces intense vasoconstriction and platelet aggregation 10 . TXA 2 also induces increased pulmonary resistance and permeability 11 .
In this study, the effects of unwashed shed blood autotransfusion on pulmonary vascular and right ventricular function after cardiac surgery were evaluated by measuring right ventricular ejection fraction (RVEF), right ventricular end-diastolic volume index (RVEDVI), mean pulmonary artery pressure (MPAP), pulmonary capillary wedge pressure (PCWP), pulmonary vascular resistance index (PVRI), central venous pressure (CVP), mean arterial pressure (MAP), cardiac output (CO), and systemic vascular resistance index (SVRI) using a RVEF thermodilution pulmonary artery catheter. Changes in plasma thromboxane B 2 (TXB 2 ) and 6-keto-PGF 1α levels, which are stable metabolites of TXA 2 and prostacyclin (PGI 2 ) respectively, were measured to assess the relation between pulmonary vascular function and TXA 2 following unwashed shed blood infusion.
PATIENTS AND METHODS
Ten male ASA class 2 patients who underwent elective myocardial revascularization were infused with unwashed mediastinal shed blood after their operations. Haemodynamic changes following autotransfusion were investigated in these 10 patients and the plasma TXB 2 and 6-keto-PGF 1α levels were measured in five of them. Informed consent was obtained from all subjects and the study protocol was approved by the university institutional review committee. Anaesthesia was induced with fentanyl 50 µg.kg -1 , pancuronium 0.1 mg.kg -1 and diazepam 0.2 mg.kg -1 administered intravenously while the patients were receiving 100% oxygen. After tracheal intubation, anaesthesia was maintained with additional intravenous doses of fentanyl, diazepam and pancuronium as necessary. A left radial arterial catheter and a flow-directed pulmonary artery catheter (via the right internal jugular vein, RVEF/volumetric oximetry thermo-dilutional catheter, Baxter Healthcare Corp., Irvine, CA, U.S.A.) were placed. Systemic anti-coagulation for cardiopulmonary bypass (CPB) was induced with heparin and protamine sulphate was used to completely reverse the effect of heparin as monitored by activated clotting time determinations. A cardioplegia solution containing betamethasone sodium phosphate 10 mg.l -1 and of diltiazem 5 mg.l -1 was used during aortic cross clamp. The unwashed pump blood in the collecting bottle with a 20 µm filter was reinfused at the conclusion of CPB. Nitroglycerin (0.5 to 1.0 µg.kg -1 .min -1 ) was infused continuously during the operation. Dopamine (2 to 10 µg.kg -1 .min -1 ) was infused as needed. Unwashed autotransfusion chest drainage units containing 3000 units of heparin with a 40 µm filter (Sentinel Seal, Sherwood Medical, St. Louis, MO, U.S.A.) were used to store and reinfuse the unwashed mediastinal shed blood.
All patients were admitted to the intensive care unit (ICU) following the operations and were mechanically ventilated initially. Midazolam 0.1 mg.kg -1 or butorphanol 0.02 mg.kg -1 were administered for sedation in ICU. The mediastinal unwashed shed blood was collected and stored in the drain for four hours from the start of the unwashed shed blood collection. After confirming haemodynamic stability, the unwashed shed blood reinfusion began at approximately 10 ml.kg -1 .h -1 . The infusion was limited to a maximum CVP of 10 mmHg.
Haemodynamic Data
The haemodynamic parameters assessed during the reinfusion included MAP, MPAP, CVP, PCWP, CO, RVEF, RVEDVI, SVRI, and PVRI. The thermodilution method CO and RVEF were measured by three successive injections of dextrose, and these values were averaged. The measurements were performed (1) prior to the reinfusion of the unwashed shed blood, and (2) 5 min, (3) 15 min, (4) 30 min, (5) 60 min, and (6) 120 min following infusion of the unwashed shed blood. During the infusion and measurement of haemodynamic parameters, the dose of drugs which might affect haemodynamics, such as dopamine (2.9±1.2 µg.kg -1 .min -1 ), nitroglycerin (0.9±0.2 µg.kg -1 .min -1 ) and phentolamine (2.0±0.9 µg.kg -1 .min -1 ), were not altered and sedative drugs were not administered.
TXB 2 and 6-keto-PGF 1α Measurement
In five of the patients levels of TXB 2 and 6-keto-PGF 1α were measured: (1) prior to the operation, (2) after completion of CPB but prior to protamine infusion, (3) prior to infusion of unwashed shed blood, (4) 30 min and (5) 120 min following the infusion. The TXB 2 and 6-keto-PGF 1α levels in the unwashed shed blood in the mediastinal and chest drain just prior to infusion were also measured. The blood samples for the TXB 2 and 6-keto-PGF 1α measurements were obtained via a pulmonary artery catheter and withdrawn as slowly as possible. These samples were collected into a pre-cooled glass tube containing 12 mg of sodium ethylenediamine tetra-acetic acid and 0.036 mg of indomethacin. The blood then was centrifuged at 4°C. The plasma was decanted into a plastic tube and stored at -70°C until analysis. Measurements of plasma TXB 2 and 6-keto-PGF 1α levels were performed via radioimmunoassay, by Sumitomo Metal Bioscience Co. Ltd, Tokyo, Japan.
Statistical Analysis
The results were analysed by one-way ANOVA and Fisher's protected least significant difference (PLSD) multiple comparison analysis, using Statview 4.5J (Abacus Concepts, Inc., CA, U.S.A.) on a Macintosh computer. Paired Student's t-test was also used for the comparison of hematocirt and hemoglobin levels. A P value of less than 0.05 was considered significant.
RESULTS
Patients' mean age was 62.1±5.5 years (mean ±SD), mean duration of CPB was 2.18±0.72 hours, mean duration of anesthesia 6.5±1.43 hours, mean duration of surgery 5.0±1.4 hours and the mean volume of the unwashed shed blood infusion in the ICU was 484±176 ml. No patient was re-explored for excessive bleeding and all patients survived to discharge.
It took about 30 to 60 minutes to complete the infusion of the shed blood (mean volume 484 ml infused at 10 ml.kg -1 .h -1 ). The haemodynamic changes following the start of autotransfusion are summarized in Table 1 . The HR, MAP, PCWP, CI, SVRI were not significantly affected by the infusion. The MPAP gradually increased following the onset of the transfusion and was significantly elevated at 30, 60, and 120 minutes (P<0.05). The RVEF was decreased five minutes after reinfusion and did not return to its preinfusion level until the 120 minute measurement (P<0.05). The mean PVRI at 120 minutes was 73% greater than before the infusion, which was not statistically significant. Given the large intersubject variability in PVRI and our small sample size, this is insufficient evidence to suggest that there was no clinically significant rise in PVRI. Haemoglobin concentration increased significantly 120 minutes after the autotransfusion (P<0.05).
The plasma TXB 2 level after CPB but before the 644 protamine injection was significantly higher than that before CPB and returned to the pre-CPB level before the autotransfusion (Figure 1 ). TXB 2 level in the unwashed shed blood in the drainage bottle was about 20,000 times higher than the preoperative plasma level. The plasma TXB 2 level 30 minutes following the start of reinfusion was significantly elevated but returned to its preoperative level by 120 minutes. The plasma 6-keto-PGF 1α level did not change during the perioperative period. In the collected shed blood, the 6-keto-PGF 1α level was about eight times higher than the preoperative plasma level. (Figure 1 ).
DISCUSSION
This study demonstrates that pulmonary hypertension and increase of TXB 2 level following unwashed shed blood autotransfusion were observed concurrently.
During CPB, the contact of whole blood with the bypass circuit may activate platelets, coagulation, fibrinolysis and inflammatory cascades involving complement, oxygen-free radicals, arachidonic acid metabolites, cytokines, platelet-activating factor, nitric oxide and endothelins 12 . Infusion of unwashed shed blood may also initiate many of these processes. Of the vasoactive substances, TXA 2 plays a critical role in the development of the pulmonary hypertension 11 .
The half-life of TXA 2 is approximately 30 seconds 10 . Unwashed shed blood in this study was reinfused four hours from the start of blood collection. Thus most of the TXA 2 in the drainage blood may have been inactivated and it is unlikely that only the TXA 2 caused the pulmonary vasoconstriction. In the drainage blood, the level of TXB 2 was extremely elevated, and not only TXA 2 but also TXB 2 is known to have pulmonary vasoconstrictive effects 11 . Other vasoactive substances and microaggregates in the drainage blood may induce pulmonary vasoconstriction, possibly by inducing production of TXA 2 or other vasoactive substances.
An increase in the MPAP and decrease in RVEF were observed after the autotransfusion started. RVEF is affected mainly by afterload rather than preload due to the thin-walled nature of the right ventricular structure 13, 14 . The PVRI increase (though not statistically significant) after the unwashed shed blood reinfusion, with an associated increase in MPAP and decrease in RVEF might be caused by a pulmonary vasoconstrictive substance such as TXA 2 and/or pulmonary microembolism.
The reinfusion speed of about 10 ml.kg -1 .h -1 used in this study may have caused volume overload and deterioration in cardiac function. However, the lack of significant changes in HR, MAP, CI and RVEDVI suggests that cardiac function was not significantly altered during and after autotransfusion in the patients studied. The mean volume of the reinfused shed blood in this study was 484 ml. Autotransfusion volumes of shed blood greater than 800 ml cause bleeding, haemodilution and/or an increased requirement for the transfusion of packed red blood cells 3 .
In conclusion, reinfusion of unwashed shed blood following cardiac surgery is associated with increased MPAP and TXB 2 and decreased RVEF plasma levels. The haemodynamic effects may be due to pulmonary vasoconstrictive substances such as plasma TXA 2 and/or microembolism.
